NT
LIVE

Serial Number

79325918

Owner

Novotech (Australia) Pty Ltd

Attorney

Matthew P. Hintz, Esq.

Filing Date

Oct 15, 2021

Add to watchlist:

No watchlists yet
View on USPTO

NT Trademark

Serial Number: 79325918 • Registration: 7476958

NT is a trademark filed by Novotech (Australia) Pty Ltd on October 15, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Novotech (Australia) Pty Ltd (8 trademarks)

L 3 235 Pyrmont St

Entity Type: 99

Trademark Details

Filing Date

October 15, 2021

Registration Date

August 20, 2024

Published for Opposition

June 4, 2024

Goods & Services

conducting clinical trials for others; scientific research in the nature of conducting and managing clinical trials for others, including clinical trials for pharmaceuticals, biotechnology and other related industries; scientific research in the nature of conducting clinical trials for others; providing information about the results of clinical trials conducted for others, including clinical trials for pharmaceuticals and biotechnology; scientific research; scientific research for medical purposes; providing information in the field of scientific research result statistics; providing information in the field of scientific research result biostatistics in the fields of pharmaceuticals, biotechnology and other related industries; provision of information and data relating to medical and scientific research for pharmaceuticals, biotechnology and other related industries; database design and development services to process data collected from clinical trials conducted for others; medical research services, namely, medical monitoring of clinical trials for others for research purposes in the fields of pharmaceuticals, biotechnology and other related industries; quality control audits; scientific research, namely, preparation of reports and applications to regulators relating to scientific research aspects of clinical trials; providing a website featuring technology allowing the provision and exchange of information and data exchange between scientists, manufacturers and health authorities relating to pharmaceutical and biotechnology quality standards; technical writing of clinical report forms which are required by clinical trial drug protocols

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 1, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 6, 2025 FICS
FINAL DISPOSITION PROCESSED
Feb 5, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 20, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 20, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 20, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 4, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 4, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 15, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 2, 2024 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 17, 2024 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 17, 2023 RCSC
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 9, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 19, 2023 OPNS
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 19, 2023 RCSC
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 19, 2023 OPNR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 20, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 20, 2022 GNSL
SUSPENSION LETTER WRITTEN
Oct 20, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 18, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 17, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 17, 2022 TROA
REFUSAL PROCESSED BY IB
Sep 12, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 19, 2022 RFCS
REFUSAL PROCESSED BY MPU
Aug 19, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 27, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jul 26, 2022 CNRT
ASSIGNED TO EXAMINER
Jul 22, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 23, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 19, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 18, 2021 REPR